Table 4

Biochemical characteristics: HIT and control group at baseline and post-intervention
Characteristic Baseline Post-intervention Mean difference Effect size Within group Between groups P-value
(95%CI) (Power) P- value (Post-intervention)
Adiponectin (ng ml-1) 0.985
HIT (37) 9.4 ± 6.1 7.6 ± 6.5 1.8 (-4.4 to 0.8) 0.162
Control (46) 8.1 ± 4.5 7.4 ± 6.2 0.6 (-2.3 to 1.0) 0.191
CRP (mg L-1) 0.940
HIT (36 1.3 ± 1.2 1.6 ± 1.7 0.4 (-0.2 to 1.1) 0.192
Control (43) 1.4 ± 1.4 1.6 ± 1.6 0.2 (-0.4 to 0.8) 0.459
Glucose (mMol L-1) 0.517
HIT (26) 4.9 ± 1.3 5.0 ± 1.2 0.1 (-0.6 to 0.7) 0.836
Control (38) 5.0 ± 1.0 5.2 ± 1.0 0.2 (-0.2 to 0.6) 0.434
HDL (mMol L-1) 0.694
HIT (26) 1.4 ± 0.3 1.8 ± 1.1 0.3 (-0.1 to 0.7) 0.167
Control (36) 1.4 ± 0.4 1.7 ± 1.0 0.4 (-0.01 to 0.8) 0.056
Insulin (IU ml-1) 0.235
HIT (24) 7.9 ± 7.5 8.5 ± 11.8 0.6 (-5.5 to 6.7) 0.764
Control (34) 7.3 ± 4.5 5.8 ± 4.2 1.5 (-3.6 to 0.6) 0.307
IL-6 (pg ml-1) 0.495
HIT (27) 3.4 ± 4.1 2.9 ± 3.8 0.6 (-2.1 to 0.9) 0.788
Control (40) 3.8 ± 2.9 3.9 ± 7.9 0.2 (-2.6 to 2.9) 0.149
LDL (mMol L-1) 0.402
HIT (24) 2.5 ± 1.5 1.5 ± 1.0 1.1 (-2.0 to -0.2) 0.51 (67.6%) 0.019
Control (33) 2.8 ± 1.8 1.7 ± 0.8 0.9 (-1.6 to -0.3) 0.51 (80.8%) 0.006
Total Cholesterol (mMol L-1) 0.182
HIT (28) 4.5 ± 1.8 3.8 ± 1.2 0.7 (-1.6 to 0.2) 0.149
Control (40) 4.2 ± 1.6 3.5 ± 1.3 0.7 (-1.5 to -0.05) 0.34 (56.1%) 0.036
Triglycerides (mMol L-1) 0.609
HIT (29) 1.0 ± 0.3 1.1 ± 0.4 0.1 (-0.1 to 0.3) 0.172
Control (41) 1.0 ± 0.4 1.1 ± 0.5 0.05 (-0.1 to 0.2) 0.526

Abbreviations: HIT High Intensity group, CI confidence interval, CRP C-reactive protein, HDL high-density lipoprotein cholesterol, IL-6 interleukin-6, LDL low-density lipoprotein cholesterol. Paired samples t-test was used to establish differences between post-intervention measures for each group. ANCOVA was used to test differences between the groups at post-intervention adjusted for the covariates (baseline age, sex, maturation, physical activity, total dietary fat, saturated fat and kcal/d difference as well as differences in waist circumference and shuttle run score) where appropriate.

Buchan et al.

Buchan et al. BMC Public Health 2013 13:498   doi:10.1186/1471-2458-13-498

Open Data